Cargando…
SARS-CoV-2 vaccine breakthrough infections in Virginia, January 17, 2021 – June 30, 2021
As COVID-19 vaccines moved from the controlled environment of clinical trials to use in real-world settings, it has been important to evaluate vaccine effectiveness. A retrospective cohort study was designed to identify cases of SARS-CoV-2 infection that occurred between January 17-June 30, 2021 in...
Autores principales: | Darby, Brandy, Alexander, Victoria, Murphy, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852316/ https://www.ncbi.nlm.nih.gov/pubmed/36690560 http://dx.doi.org/10.1016/j.vaccine.2023.01.041 |
Ejemplares similares
-
COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
por: Birhane, Meseret, et al.
Publicado: (2021) -
Excess deaths from COVID-19 in Japan and 47 prefectures from January through June 2021
por: Nomura, S., et al.
Publicado: (2022) -
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021
por: Braeye, Toon, et al.
Publicado: (2021) -
SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May–June 2021
por: Harris, Julie R., et al.
Publicado: (2022) -
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021
por: Alleman, Mary M., et al.
Publicado: (2021)